Kina review

What it is

Kina is an online menopause-care service operated by Stewart Ventures Inc., organised around symptoms rather than drug classes: Weight (compounded GLP-1), Energy and Focus (HRT), Sleep (HRT), Skin (a prescription GHK-Cu copper peptide cream, optionally paired with tretinoin), Hair (a prescription compound) and Longevity (NAD⁺ and glutathione injections). Prescribing runs through Arora Health & Aesthetics, described as a nationally licensed provider group specialising in hormonal health, with Dr. Sean Arora as medical director and Dr. Shannon Arora, PharmD, as clinical lead. Care is entirely online, with a short intake and free shipping.

How it works

Asynchronous and clinician-gated, with a small paid gate at the front: a consult fee — currently shown as $25 — buys clinician review, and treatment follows only if a provider finds it appropriate, with the site stating plainly that not everyone will qualify. What you get with the skin product is described concretely: a prescription-strength compounded copper peptide cream, clinician consultation and prescription, unlimited follow-up messaging and care coordination, free shipping, and optional tretinoin if the clinician recommends it. Naming the prescribing group and two individual clinicians is meaningfully above this board's norm, and the LegitScript seal resolves against an issued seal ID rather than being a badge image. The gaps are the usual two. Kina does not name the compounding pharmacy that prepares its formulations, and it publishes no state list — its own FAQ acknowledges the rules change and directs you to confirm eligibility during intake. Note also that the consult fee we found live ($25) is lower than the $50 figure that circulated earlier, so treat any quoted fee as current-at-the-time and check it yourself.

Pricing transparency

There is no published price for the GHK-Cu cream. The product page says "personalized pricing" and the only figure stated on the skin flow is the consult fee, so we are not quoting a peptide number. Kina's GLP-1 program does publish a starting figure of $179/mo with no membership fee, and it is FSA/HSA eligible with free shipping and cancel-anytime terms — but that is a weight-loss price and tells you nothing about the cream. Before paying the consult fee, ask what a month of the cream costs, whether the tretinoin pairing is billed separately, how many grams the shipment contains and at what GHK-Cu concentration, since that is the variable that actually differs between prescription copper-peptide products. Ask too whether the price changes if a clinician adjusts the formulation.

Branded vs compounded

Compounded; not FDA-approved. Prescription required only if a licensed provider finds it appropriate. Kina states this in its own words — compounded medications are personalised preparations made by licensed US pharmacies and are not FDA-approved — which is the right disclosure, though it does not name the pharmacy, and compounded preparations are not reviewed by the FDA for purity and potency the way approved drugs are. On the evidence, GHK-Cu is a naturally occurring copper-binding tripeptide with a genuinely interesting laboratory story: it modulates copper transport and has been shown in cell and animal work to influence collagen synthesis and wound repair. What does not exist is controlled human outcome trial data supporting the firmness, fine-line and tone claims the category is sold on — the human work is small, largely cosmetic-formulation studies, and a prescription-strength concentration raises the dose without producing the missing evidence. Kina's Longevity line is subject to the same limit from the other direction: injected NAD⁺ and glutathione have no controlled human outcome trials, while the NAD⁺ forms with human data are the oral precursors NR and NMN, which raise blood NAD⁺ — a biomarker, not an outcome. Individual results vary.

Pros and watch-outs

The evidence behind what Kina prescribes

We grade the molecules, not the marketing. Here is what the human data actually shows for each thing on their menu.

• GHK-Cu: the copper peptide between real skincare and overclaim

  A decades-deep molecule with a credible topical story — and systemic anti-aging claims that outrun the human data.

• NAD+ precursors (NR and NMN): what the human trials actually show

  They raise NAD+ and look safe short-term — but human evidence is surrogate-marker level, and no trial shows they extend healthspan.

• Glutathione: the master antioxidant, and where the evidence actually is

  Oral glutathione really does raise your body stores (a 6-month RCT proved it) — but the longevity and detox claims are unproven, skin-lightening is modest, and IV glutathione is the most marketed, least evidenced route. The precursors may be the smarter bet.

How Kina compares

A few alternatives worth a look, depending on what you’re optimizing for.

• LHLevers Health

  NAD⁺ injections priced openly on a storefront rather than quoted after intake

  See Levers Health →
• KMKin Meds

  Comparing injected, intranasal and sublingual NAD⁺ at published prices in one place

  See Kin Meds →
• LTLttl

  Shoppers who want every commitment tier priced openly before they hand over anything

  See Lttl →